| Market Cap | ₹1,344Cr |
| ROE | 17.30% |
| P/E Ratio(TTM) | 21.68 |
| EPS(TTM) | 9.28 |
| P/B Ratio | 5.31 |
| Dividend Yield | 1.24% |
| Industry P/E | 40.20 |
| Book Value | 37.87 |
| Debt to Equity | 0.03 |
| Face Value | 2 |
| Parent Organisation | Jagsonpal Pharmaceuticals Limited. |
| Managing Director | Mr. Manish Gupta |
| NSE Symbol | JAGSNPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 37.64 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.38 | ||
| Cohance Lifesciences | NA (0.00%) | 71.87 | ||
| Wockhardt | NA (0.00%) | -417.83 |